Company Info
Phone(206) 838-5110
Year Established
2003
Ticker
IBRX
Exchange
NASDAQ
Contacts
Richard AdcockPresident & CEO
Helen Luu
CCO
David Sachs
CFO
Patrick Soon-Shiong, M.D.
Chair
Leonard S. Sender, M.D.
COO
Jason Liljestrom, Esq.
General Counsel
Enrique Dilon�
CTO
Sandeep ﾓBobbyﾔ Reddy, M.D.
CMO
Hans Klingemann, M.D., Ph.D.
CSO
Company Description
ImmunityBio, formerly Etubics and NantCell, develops targeted immunotherapies and vaccine products for a wide range of resilient diseases.
